Keywords: irbesartan, debuts, uk, germany, sanofi, angiotensin, ii

Irbesartan Debuts In The UK And Germany

Article | 25 September 1997

Print This

Sanofi's angiotensin II receptor antagonist Aprovel (irbesartan) has nowbeen launched for the treatment of hypertension in the UK, its first ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in